Nutrition Intervention in Older Adults at Risk of Malnutrition

Malnutrition Clinical Trial

Official title:

Effects of Oral Nutritional Supplement With Dietary Counseling in Community Dwelling Older Adults at Risk of Malnutrition

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05682781
• Other study ID #: BL64
• Status: Active, not recruiting
• Phase: N/A
• Start date: March 9, 2023
• Est. completion date: March 20, 2024

Study information

• Verified date: January 2024
• Source: Abbott Nutrition
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Thailand is one of the fastest aging countries and older adults are at greater risk of having inadequate nutrient intake and malnutrition (undernutrition). In the community setting, malnutrition has been linked to low muscle mass, sarcopenia, increased incidence of disability and functional impairments. The objective of this prospective, multicenter, randomized controlled, open-label, parallel-design study is to determine the effects of an oral nutritional supplement with dietary counseling on body weight, in comparison with dietary counseling alone, in community dwelling older adults at risk of malnutrition.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 196
• Est. completion date: March 20, 2024
• Est. primary completion date: March 20, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

1. Male or female participant aged =60 years at risk of undernutrition.

2. Community-dweller.

3. Participant is community ambulant.

4. Participant does not have any chronic disease(s) or has stable chronic disease(s) at study entry.

5. Participant voluntarily signed and dated on an IRB approved informed consent form (ICF) and provided authorization prior to study participation.

6. Participant is able to communicate and follow instructions.

7. Participant is able to consume food and beverages orally.

8. Participant is willing to refrain from taking non-study oral nutritional supplements.

9. Participant is able and willing to follow study procedures and record data in diary and complete forms or assessments as needed.

Exclusion Criteria:

1. Participant diagnosed with type 1 or type 2 diabetes.

2. Participant has active infectious disease.

3. Participant has been diagnosed with severe gastrointestinal disorders.

4. Participant has been diagnosed with advanced renal disease or end stage organ or pre-terminal diseases or acute myocardial infarction within the last 30 days from the baseline visit.

5. Participant has active malignancy within the last five years, or is in current treatment for malignancy.

6. Participant has any condition, which in the investigator's opinion, makes him or her unsuitable for inclusion in the study.

7. Participant is taking part in another study that has not been approved as a concomitant study.

8. Participant has disorder or other conditions, that may interfere with study product consumption or compliance with study protocol procedures.

9. Participant has been diagnosed or known to be allergic or intolerant to milk products.

10. Participant has continuous oral nutritional supplement usage for 30 days prior to the baseline visit.

11. Participant has been taking herbals, dietary supplements, or medications during the past 30 days prior to the baseline visit that could profoundly affect body weight or appetite.

12. Participant has clinically significant ascites, pleural effusion, edema, or dehydration

Related Conditions & MeSH terms

• Malnutrition

Intervention

Dietary Supplement:
• Oral Nutritional Supplement
Oral Nutritional Supplement

Other:
• Dietary Counseling
Dietary Counseling

Locations

Country	Name	City	State
Thailand	Faculty of Medicine Siriraj Hospital, Mahidol University	Bangkoknoi	Bangkok
Thailand	The Department of Internal Medicine, Faculty of Medicine, Thammasat University	Pathumthani

Sponsors (1)

Lead Sponsor	Collaborator
Abbott Nutrition

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in body weight	Measured in kg	Baseline to 60 days
Secondary	Malnutrition risk	Malnutrition Universal Screening Tool is a widely used screening tool for malnutrition. It classifies participants into one of three nutrition status categories: low risk/score = 0, medium risk/score = 1, and high risk/score = 2. Minimum value = 0, Maximum value = 6. Higher score indicates worse outcome, i.e., increased risk of malnutrition.	Baseline, Study Day 30 and Study Day 60
Secondary	Body mass index (BMI)	Weight (kg)/Height (m)2	Baseline, Study Day 30 and Study Day 60
Secondary	Mid-upper arm circumference	Measured in cm	Baseline, Study Day 30 and Study Day 60
Secondary	Change in body weight	Measured in kg	Baseline and Study Day 30
Secondary	Energy intake	24-Hour Dietary Recall: Researcher-led interview on food and drink intake the previous day. Nutrient analysis will be performed using a dietary analysis program.	Baseline, Study Day 30 and Study Day 60
Secondary	Nutrient intake	24-Hour Dietary Recall: Researcher-led interview on food and drink intake the previous day. Nutrient analysis will be performed using a dietary analysis program.	Baseline, Study Day 30 and Study Day 60